An investigation into a clinical test in France that left one person dead and put five in the hospital has found evidence of brain damage in people who took high doses of the experimental pain medicine.
The early-stage clinical study, conducted by Biotrial in France, was halted in January when the side effects surfaced. It was the first time the drug, made by the Portuguese company Bial and known as “BIA 10-2474,” was tested in humans.
